A team of investigators sought to compare the safety and efficacy of proposed biosimilar FYB201 to reference ranibizumab in treatment-naive patients with subfoveal neovascular age-related macular degeneration.
Yellow-tinted spectacle lenses score low on quality-of-life test and only moderately improve acuity.
Researchers examine the impact of progression of geographic atrophy with subsequent exudative neovascular disease in age-related macular degeneration.
Study shows how lesion morphology is associated with rates of recurrence.
Higher dietary intake of multiple nutrients may be associated with decreased progression of age-related macular degeneration.
Research used driving and reading to measure visual usefulness for patients with Wet AMD.
A new study reveals the incidence of late stage age-related macular degeneration by region and ethnicity.
Investigators uncover which patients are more likely to misidentify their treatment eye.
Researchers evaluate whether patients with central vision loss experience binocular advantage or disadvantage when reading.
Researchers found that, while patients who have a lapse in anti-VEGF injections can regain central subfield thickness after missing 12 months of visits, losses to visual acuity are permanent.
